170 related articles for article (PubMed ID: 19331713)
1. Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?
Shaukat A; Parekh M; Lipscomb J; Ladabaum U
Int J Technol Assess Health Care; 2009 Apr; 25(2):222-31. PubMed ID: 19331713
[TBL] [Abstract][Full Text] [Related]
2. Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis.
Arguedas MR; Heudebert GR; Wilcox CM
Aliment Pharmacol Ther; 2001 May; 15(5):631-8. PubMed ID: 11328256
[TBL] [Abstract][Full Text] [Related]
3. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
4. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
Pence BC; Belasco EJ; Lyford CP
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
[TBL] [Abstract][Full Text] [Related]
5. Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer.
Saini SD; Schoenfeld P; Vijan S
Gastroenterology; 2010 Jun; 138(7):2292-9, 2299.e1. PubMed ID: 20226186
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
7. Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations.
Becker F; Nusko G; Welke J; Hahn EG; Mansmann U
Int J Colorectal Dis; 2007 Aug; 22(8):929-39. PubMed ID: 17279350
[TBL] [Abstract][Full Text] [Related]
8. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer.
Squires H; Tappenden P; Cooper K; Carroll C; Logan R; Hind D
Clin Ther; 2011 Sep; 33(9):1289-305. PubMed ID: 21840057
[TBL] [Abstract][Full Text] [Related]
10. Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy.
Pickhardt PJ; Hassan C; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
AJR Am J Roentgenol; 2008 Jan; 190(1):136-44. PubMed ID: 18094303
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of postpolypectomy colonoscopy surveillance using Japanese data.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
Dig Endosc; 2019 Jan; 31(1):40-50. PubMed ID: 30062760
[TBL] [Abstract][Full Text] [Related]
12. Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population.
Huang Y; Gong W; Su B; Zhi F; Liu S; Bai Y; Jiang B
J Gastroenterol; 2010 Aug; 45(8):838-45. PubMed ID: 20336471
[TBL] [Abstract][Full Text] [Related]
13. Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis.
Veettil SK; Kew ST; Lim KG; Phisalprapa P; Kumar S; Lee YY; Chaiyakunapruk N
BMC Gastroenterol; 2021 Mar; 21(1):130. PubMed ID: 33743605
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.
Rubenstein JH; Waljee AK; Jeter JM; Velayos FS; Ladabaum U; Higgins PD
Am J Gastroenterol; 2009 Sep; 104(9):2222-32. PubMed ID: 19491824
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer in patients under close colonoscopic surveillance.
Robertson DJ; Greenberg ER; Beach M; Sandler RS; Ahnen D; Haile RW; Burke CA; Snover DC; Bresalier RS; McKeown-Eyssen G; Mandel JS; Bond JH; Van Stolk RU; Summers RW; Rothstein R; Church TR; Cole BF; Byers T; Mott L; Baron JA
Gastroenterology; 2005 Jul; 129(1):34-41. PubMed ID: 16012932
[TBL] [Abstract][Full Text] [Related]
16. Benefit-risk analysis of different risk-related surveillance schedules following colorectal polypectomy.
Becker F; Nusko G; Welke J; Hahn EG; Mansmann U
Hepatogastroenterology; 2007 Dec; 54(80):2249-58. PubMed ID: 18265643
[TBL] [Abstract][Full Text] [Related]
17. Colonoscopy surveillance after polypectomy may be extended beyond five years.
Miller HL; Mukherjee R; Tian J; Nagar AB
J Clin Gastroenterol; 2010 Sep; 44(8):e162-6. PubMed ID: 20628313
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of small (6- to 9-mm) polyps detected at screening CT colonography: a cost-effectiveness analysis.
Pickhardt PJ; Hassan C; Laghi A; Zullo A; Kim DH; Iafrate F; Morini S
AJR Am J Roentgenol; 2008 Nov; 191(5):1509-16. PubMed ID: 18941093
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopy surveillance after polypectomy and colorectal cancer resection.
Brooks DD; Winawer SJ; Rex DK; Zauber AG; Kahi CJ; Smith RA; Levin B; Wender R; ;
Am Fam Physician; 2008 Apr; 77(7):995-1002. PubMed ID: 18441865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
